Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05086354 · ClinicalTrials.gov registry record · NA
Examining a Training Program for for Acute Lymphoblastic Leukemia Childhood Cancer Survivors
A NA study of Childhood Cancer, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT05086354: Completed NA study of Childhood Cancer, sponsored by University of Maryland, Baltimore.
NCT05086354 is a NA study of Childhood Cancer that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 10 participants, below the 1,472-participant average among 23 other Childhood Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05086354, a NA study of Childhood Cancer, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy, with the peak incidences occurring in children two to five years of age. Children with ALL received neurotoxic chemotherapy agents for two to three years that causes decreased distal muscle strength and poor timing of muscle activation. After completion of medical treatment, ALL childhood cancer survivors (ALL CCS) are more likely to have an inactive lifestyle, resulting in life-long gross motor proficiency differences compared to their peers. ALL CCS typically do not utilize physical therapists' expertise after medical treatment has been completed. There are limited physical therapy (PT) intervention studies for ALL CCS.
Primary Outcome
Bruininks-Oseretsky Test of Motor Proficiency 2nd edition (BOT-2) (subtest 4, 5, 6, 8: bilateral coordination, balance, running speed and agility, and strength). The BOT-2 is a reliable and valid norm-referenced instrument designed for children and adolescents 4-21 years old.
Conditions Studied
Interventions
- BEHAVIORAL JUMP
Study Locations (1)
Maryland
- University of Maryland School of Medicine Dept. of Physical Therapy & Rehabilitation Science - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-03-16 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
What the finished NCT05086354 record still lists
NCT05086354 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,472-participant average among 23 other Childhood Cancer trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Childhood Cancer appearing as the primary indexed condition, and to 1 intervention - of which JUMP is the first listed.
NCT05086354 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT05086354 about?
NCT05086354 is a clinical study titled "Examining a Training Program for for Acute Lymphoblastic Leukemia Childhood Cancer Survivors". Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy, with the peak incidences occurring in children two to five years of age. Children with ALL received neurotoxic chemotherapy agents for two to three years that causes decreased distal muscle strength and poor timing of muscle...
What is the current status of trial NCT05086354?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2018-03-16. Estimated completion is 2021-12-31.
What conditions does trial NCT05086354 study?
This clinical trial studies the following conditions: Childhood Cancer.
What interventions are being tested in trial NCT05086354?
The interventions under investigation include: JUMP (BEHAVIORAL).
Who is sponsoring clinical trial NCT05086354?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05086354 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Childhood Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05086354's enrollment target sits among peer trials
10 23rd of 23 the lowest of 23 other Childhood Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Childhood Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preparing for Life and Academics for Young Childhood Cancer Survivors
RECRUITING · NA
-
Assessment of Remote Approaches for Identification of Autonomic Dysfunction Among Survivors of Leukemia and Lymphoma
RECRUITING · NA
-
Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors
RECRUITING · NA
-
Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors
RECRUITING · NA
-
Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up Care
RECRUITING · NA
-
Proof-of-Concept Testing of the Cardiovascular Health Equity Through Food (CHEF) Intervention in Childhood Cancer Survivors
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI